15:26 Mon 23 Sep 2019
Deltex Med Grp PLC - Exercise of Options
("
Exercise of Options
Application has been made for the 1,250,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"), and dealings are expected to commence on
The total number of ordinary shares in issue following Admission will be 517,368,109. The Company does not hold any shares in treasury. Accordingly, the figure of 517,368,109 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the
For further information, please contact:-
|
01243 774 837 |
|
|
|
|
|
|
|
|
Nominated Adviser & Broker |
|
Arden Partners plc |
020 7614 5900 |
|
|
|
|
|
|
Joint Broker |
|
|
0203 621 4120 |
|
Notes for Editors
Group goal
Haemodynamic management is now becoming widely accepted as a vital part of the anaesthesia protocol for surgical patients. Consequently, the Group's focus is on maximising value from the opportunities presented, as enhanced haemodynamic management is adopted into routine clinical practice around the world. The Group aims to provide clinicians with a single platform - a 'haemodynamic workstation' - which offers them a range of technologies from simple to sophisticated to be deployed according to the patient's condition as well as the skill and expertise of the user. Doing this will enable the Group to partner healthcare providers to support modern haemodynamic management across the whole hospital.
The Group is currently in the implementation phase of achieving this goal in a number of territories worldwide, operating directly in the
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE